Read beyond the abstract
Check study type, population or model, endpoints and limitations. A headline finding can lose important context when condensed into marketing language.
Preserve the evidence level
Laboratory and animal findings should not become claims of clinical benefit. A source about one formulation may not support a different product.
Assign the right reviewer
Writers can organize sources, while qualified subject-matter reviewers assess technical and clinical interpretations. Keep that responsibility explicit.
Put it to work
A practical next step
Maintain a claim ledger with the exact statement, source, limitations and reviewer.
Keep the evidence with the decision.
Save the baseline, the reason for the change and the person responsible for checking it. This makes the work easier to review later and helps your team distinguish a verified improvement from an untested assumption.
This note provides a planning framework. The right implementation depends on your business model, market, website and available records. Where a decision involves scientific interpretation, clinical services or legal status, use the appropriate qualified reviewer rather than treating marketing guidance as approval.
Sources and review context.
For the limits of research-use wording, see the FDA’s Gram Peptides warning letter. For search-system guidance, consult Google’s helpful content guidance. These sources provide context, not approval of a specific business.
Related agency support
Content Review ↗
Review the service scope and use the briefing tool to describe your current situation.